Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
doi: 10.1002/hipo.22837 241 LiTJiaoJJSuQHolscherCZhangJYanXDet al
Lancet Diabetes Endocrinol 6(8):605617 Tuttle KR, Lakshmanan MC, Rayner B, Busch RS, Zimmermann AG, Woodward DB et al (2018b) Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
Potential clients are asking AI-powered tools where to go next
The trial was double-blinded, meaning neither the investigators nor the persons with Parkinsons were made aware of who was actually receiving an active drug (rather than a placebo/inactive drug)
US$ 21.95
US$ 24.76
US$ 23.71
US$ 29.05
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
![Professor Oak's New Theory (101/123) (League Promo) [HeartGold & SoulSilver: Base Set] Dragons of Tarkir Promos](https://cdn.shopify.com/s/files/1/0378/1125/7476/products/54c72f8f-a064-46bd-b9e2-817ec7174f98_8f16c5e7-0bee-4aff-a0e0-063aa1aaa342.jpg?v=1696333685)